Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Internship and Residency | 2 | 2025 | 438 | 1.230 |
Why?
|
| Social Media | 3 | 2025 | 86 | 0.970 |
Why?
|
| Students, Medical | 1 | 2025 | 196 | 0.790 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 2 | 2018 | 106 | 0.510 |
Why?
|
| Pharmaceutical Preparations | 1 | 2017 | 90 | 0.490 |
Why?
|
| Respiratory Center | 1 | 2013 | 3 | 0.420 |
Why?
|
| Organophosphate Poisoning | 1 | 2013 | 14 | 0.410 |
Why?
|
| Respiratory Insufficiency | 1 | 2013 | 42 | 0.400 |
Why?
|
| Pneumoperitoneum | 1 | 2010 | 3 | 0.350 |
Why?
|
| Colonoscopy | 1 | 2010 | 67 | 0.340 |
Why?
|
| Faculty, Medical | 2 | 2023 | 137 | 0.320 |
Why?
|
| Drug Overdose | 2 | 2019 | 104 | 0.270 |
Why?
|
| Ethanol | 2 | 2019 | 250 | 0.260 |
Why?
|
| Poisoning | 3 | 2020 | 29 | 0.240 |
Why?
|
| Inhibin-beta Subunits | 2 | 2003 | 7 | 0.230 |
Why?
|
| Humans | 18 | 2025 | 40217 | 0.230 |
Why?
|
| Activins | 2 | 2003 | 50 | 0.220 |
Why?
|
| Androgens | 1 | 2003 | 43 | 0.210 |
Why?
|
| Plant Poisoning | 1 | 2023 | 1 | 0.210 |
Why?
|
| Foodborne Diseases | 1 | 2023 | 5 | 0.210 |
Why?
|
| Hallucinogens | 1 | 2023 | 12 | 0.210 |
Why?
|
| Cannabis | 1 | 2023 | 33 | 0.200 |
Why?
|
| Female | 11 | 2025 | 20392 | 0.200 |
Why?
|
| Male | 10 | 2025 | 18271 | 0.190 |
Why?
|
| Prostatic Neoplasms | 2 | 2003 | 249 | 0.190 |
Why?
|
| Education, Medical, Graduate | 1 | 2023 | 192 | 0.180 |
Why?
|
| Sex Factors | 2 | 2019 | 646 | 0.170 |
Why?
|
| Toxicology | 2 | 2019 | 32 | 0.170 |
Why?
|
| Clinical Competence | 1 | 2023 | 448 | 0.160 |
Why?
|
| Cross-Sectional Studies | 1 | 2025 | 1668 | 0.160 |
Why?
|
| Testicular Hormones | 3 | 2003 | 10 | 0.150 |
Why?
|
| Surveys and Questionnaires | 1 | 2025 | 1792 | 0.150 |
Why?
|
| Suicide, Attempted | 1 | 2019 | 78 | 0.150 |
Why?
|
| Efficiency | 1 | 2018 | 29 | 0.150 |
Why?
|
| Writing | 1 | 2018 | 36 | 0.140 |
Why?
|
| Social Support | 2 | 2018 | 274 | 0.140 |
Why?
|
| Registries | 4 | 2023 | 571 | 0.140 |
Why?
|
| Cardiovascular Agents | 1 | 2018 | 62 | 0.140 |
Why?
|
| Adult | 5 | 2025 | 10255 | 0.140 |
Why?
|
| Glycoproteins | 3 | 2003 | 151 | 0.140 |
Why?
|
| NF-kappa B | 3 | 2004 | 366 | 0.140 |
Why?
|
| Retrospective Studies | 2 | 2023 | 3138 | 0.140 |
Why?
|
| Systems Integration | 1 | 2017 | 23 | 0.130 |
Why?
|
| Transducers | 1 | 2017 | 16 | 0.130 |
Why?
|
| Glass | 1 | 2017 | 21 | 0.130 |
Why?
|
| Community Networks | 1 | 2017 | 28 | 0.130 |
Why?
|
| Drug Approval | 1 | 2017 | 20 | 0.130 |
Why?
|
| Morbidity | 1 | 2017 | 67 | 0.130 |
Why?
|
| Smartphone | 1 | 2017 | 42 | 0.130 |
Why?
|
| United States Food and Drug Administration | 1 | 2017 | 58 | 0.130 |
Why?
|
| Weight Reduction Programs | 1 | 2017 | 49 | 0.130 |
Why?
|
| Body Weight | 1 | 2017 | 313 | 0.120 |
Why?
|
| Analgesics, Opioid | 1 | 2018 | 306 | 0.110 |
Why?
|
| Research Design | 1 | 2017 | 419 | 0.110 |
Why?
|
| Women's Health | 1 | 2017 | 320 | 0.110 |
Why?
|
| Telemedicine | 1 | 2017 | 172 | 0.110 |
Why?
|
| Diagnostic Errors | 1 | 2014 | 59 | 0.110 |
Why?
|
| Pneumonia | 1 | 2014 | 95 | 0.100 |
Why?
|
| Organophosphorus Compounds | 1 | 2013 | 22 | 0.100 |
Why?
|
| United States | 3 | 2019 | 4886 | 0.100 |
Why?
|
| Nerve Net | 1 | 2013 | 50 | 0.100 |
Why?
|
| Acute Disease | 1 | 2013 | 421 | 0.100 |
Why?
|
| Intestinal Perforation | 1 | 2010 | 4 | 0.090 |
Why?
|
| Cell Division | 4 | 2003 | 387 | 0.080 |
Why?
|
| Radiography | 1 | 2010 | 273 | 0.080 |
Why?
|
| Colon | 1 | 2010 | 103 | 0.080 |
Why?
|
| Obesity | 1 | 2017 | 970 | 0.080 |
Why?
|
| Immediate-Early Proteins | 3 | 2004 | 38 | 0.080 |
Why?
|
| Breast Neoplasms | 3 | 2004 | 808 | 0.080 |
Why?
|
| Child, Preschool | 2 | 2023 | 1203 | 0.070 |
Why?
|
| Middle Aged | 4 | 2019 | 10090 | 0.070 |
Why?
|
| S Phase | 2 | 2003 | 74 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2023 | 1958 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 2 | 2003 | 310 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2004 | 156 | 0.060 |
Why?
|
| Cell Cycle | 2 | 2003 | 352 | 0.060 |
Why?
|
| Child | 2 | 2023 | 2856 | 0.060 |
Why?
|
| E2F Transcription Factors | 1 | 2003 | 14 | 0.050 |
Why?
|
| Smad3 Protein | 1 | 2003 | 13 | 0.050 |
Why?
|
| E2F1 Transcription Factor | 1 | 2003 | 14 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2003 | 25 | 0.050 |
Why?
|
| Neoplasm Proteins | 2 | 2003 | 229 | 0.050 |
Why?
|
| Retinoblastoma Protein | 1 | 2003 | 28 | 0.050 |
Why?
|
| Prostate-Specific Antigen | 1 | 2003 | 51 | 0.050 |
Why?
|
| Adolescent | 2 | 2023 | 4034 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2003 | 2581 | 0.050 |
Why?
|
| Psychotropic Drugs | 1 | 2023 | 60 | 0.050 |
Why?
|
| Aged | 4 | 2019 | 8182 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2004 | 370 | 0.050 |
Why?
|
| Animals | 5 | 2013 | 16893 | 0.050 |
Why?
|
| Apoptosis | 2 | 2003 | 893 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2003 | 277 | 0.050 |
Why?
|
| Growth Inhibitors | 1 | 2002 | 23 | 0.050 |
Why?
|
| Prostate | 1 | 2002 | 36 | 0.050 |
Why?
|
| Interferon-gamma | 1 | 2003 | 459 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2003 | 803 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2003 | 364 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2023 | 459 | 0.040 |
Why?
|
| DNA-Binding Proteins | 2 | 2003 | 1044 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2020 | 179 | 0.040 |
Why?
|
| Age Distribution | 1 | 2020 | 183 | 0.040 |
Why?
|
| Suicidal Ideation | 1 | 2019 | 75 | 0.040 |
Why?
|
| Research Support as Topic | 1 | 2018 | 24 | 0.040 |
Why?
|
| Anti-Mullerian Hormone | 3 | 2003 | 51 | 0.040 |
Why?
|
| Bites and Stings | 1 | 2018 | 6 | 0.040 |
Why?
|
| Time Factors | 2 | 2020 | 2422 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2020 | 463 | 0.040 |
Why?
|
| Polypharmacy | 1 | 2018 | 49 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2023 | 563 | 0.040 |
Why?
|
| Mentors | 1 | 2018 | 86 | 0.030 |
Why?
|
| Medication Errors | 1 | 2018 | 93 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2003 | 1340 | 0.030 |
Why?
|
| Telemetry | 1 | 2017 | 15 | 0.030 |
Why?
|
| Infant | 1 | 2020 | 989 | 0.030 |
Why?
|
| Diffusion of Innovation | 1 | 2017 | 52 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2017 | 71 | 0.030 |
Why?
|
| Forecasting | 1 | 2017 | 165 | 0.030 |
Why?
|
| Equipment Design | 1 | 2017 | 204 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2003 | 1328 | 0.030 |
Why?
|
| Mobile Applications | 1 | 2017 | 100 | 0.030 |
Why?
|
| Biosensing Techniques | 1 | 2017 | 109 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 2014 | 24 | 0.030 |
Why?
|
| Hospitals, Urban | 1 | 2014 | 25 | 0.030 |
Why?
|
| Rhode Island | 1 | 2014 | 58 | 0.030 |
Why?
|
| Internet | 1 | 2017 | 338 | 0.030 |
Why?
|
| Radiography, Thoracic | 1 | 2014 | 48 | 0.030 |
Why?
|
| Pregnancy | 1 | 2019 | 1664 | 0.030 |
Why?
|
| Mice, Inbred C3H | 2 | 2003 | 149 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2003 | 125 | 0.020 |
Why?
|
| Emergency Medical Services | 1 | 2014 | 169 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 2877 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2014 | 246 | 0.020 |
Why?
|
| Rats | 2 | 2004 | 1616 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2003 | 582 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 663 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2003 | 1072 | 0.020 |
Why?
|
| Membrane Proteins | 2 | 2003 | 730 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2004 | 61 | 0.010 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2003 | 5 | 0.010 |
Why?
|
| Activin Receptors, Type I | 1 | 2003 | 14 | 0.010 |
Why?
|
| Receptors, Growth Factor | 1 | 2003 | 17 | 0.010 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2003 | 24 | 0.010 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2003 | 22 | 0.010 |
Why?
|
| Receptors, Peptide | 1 | 2003 | 22 | 0.010 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2003 | 5 | 0.010 |
Why?
|
| Transcription Factor RelA | 1 | 2003 | 34 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2003 | 106 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 465 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 663 | 0.010 |
Why?
|
| Biopsy | 1 | 2003 | 228 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2003 | 192 | 0.010 |
Why?
|
| Ribonucleases | 1 | 2002 | 27 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2002 | 50 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2002 | 127 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2002 | 193 | 0.010 |
Why?
|
| CHO Cells | 1 | 2002 | 178 | 0.010 |
Why?
|
| Cricetinae | 1 | 2002 | 343 | 0.010 |
Why?
|
| Gene Expression | 1 | 2003 | 678 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2002 | 290 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2002 | 497 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 419 | 0.010 |
Why?
|
| Mice | 2 | 2003 | 8809 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 586 | 0.010 |
Why?
|
| Models, Biological | 1 | 2002 | 1007 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2002 | 1254 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2003 | 3136 | 0.010 |
Why?
|